Background This study presents the results of the minimum inhibitory concentration (MIC)
assay of a series of nosodes: namely Escherichia coli, Klebsiella pneumoniae, Salmonella …

Background Cutaneous warts represent a challenging condition to treat. Objective To
evaluate the safety and efficacy of intralesional injection of MMR (mumps, measles, and …

Background Human papilloma virus infects and proliferates in skin or mucosal cells to cause
warts. Most of the current therapeutic modalities are ablative, act only on treated lesions, and …

INTRODUCTION: Anogenital warts (AGWs) are one of the leading sexually transmitted
infections in the world. This condition poses a number of challenges to dermatologists …

Background A wart is a mucocutaneous illness caused by the growth of HPV-infected skin or
mucosal cells. Intralesional immunotherapy makes use of the immune system's ability to …

The infection of keratinocytes by human papilloma virus (HPV) causes warts. These are of
different types based on morphological and anatomical grounds. This has led to the …

Background Intralesional immunotherapy has been effectively used in the treatment of warts;
however, comparative studies between different antigens are limited. Objective To evaluate …

Background: Cutaneous warts are common dermatological conditions caused by the human
papilloma virus (HPV). Immunotherapy has now found a significant place in the treatment of …

Background: Recurrent or resistant warts may be due to defective cell-mediated immune
response. Immunotherapy is directed at manipulating the immune system to achieve an anti …

Background: Warts are benign tumors caused by infection of keratinocytes with human
papillomavirus. Various modalities are available for the treatment of cutaneous warts such …